Position in DXCM
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$33,675,000
+$2,275,000 QoQ
Shares Held
500,000
0.0% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#112
of 971 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026OFI INVEST ASSET MANAGEMENT holds $128,174,496 across 7 Medical Devices names. DXCM ranks #2 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
458,427 | $41,469,306 | |
| 2 | DXCM |
Dexcom Inc
This page
|
500,000 | $33,675,000 | |
| 3 | SYK |
Stryker Corp
|
88,370 | $27,822,410 | |
| 4 | BSX |
Boston Scientific Corp
|
529,615 | $22,603,968 | |
| 5 | ABT |
Abbott Laboratories
|
16,123 | $1,463,001 | |
| 6 | PODD |
Insulet Corp
|
4,640 | $706,440 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
6,786 | $434,371 |
All Filings in DXCM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,675,000 | 500,000 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $31,400,000 | 500,000 | Shares | Sole | 2026-05-05 | |
| 2025-09-30 | $104,232 | 1,549 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $131,633 | 1,508 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $62,621 | 917 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $49,461 | 636 | Shares | Sole | 2025-02-07 | |
| 2024-06-30 | $14,669,898 | 129,387 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $33,704 | 243 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $34,497 | 278 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,497 | 284 | Shares | Sole | 2023-11-02 | |
| No filing history on record for this holder in this stock. | ||||||